A review on machine learning approaches and trends in drug discovery

[Display omitted] •Machine Learning in drug discovery has greatly benefited the pharmaceutical industry.•Application of machine algorithms must entail a robust design in real clinical tasks.•Trending machine learning algorithms in drug design: NB, SVM, RF and ANN. Drug discovery aims at finding new...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Computational and structural biotechnology journal Ročník 19; s. 4538 - 4558
Hlavní autoři:	Carracedo-Reboredo, Paula, Liñares-Blanco, Jose, Rodríguez-Fernández, Nereida, Cedrón, Francisco, Novoa, Francisco J., Carballal, Adrian, Maojo, Victor, Pazos, Alejandro, Fernandez-Lozano, Carlos
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Elsevier B.V 01.01.2021 Research Network of Computational and Structural Biotechnology Elsevier
Témata:	biotechnology Cheminformatics chemoinformatics computer science Deep Learning Drug Discovery drugs Machine Learning Molecular Descriptors precision medicine QSAR Review ANN Cheminformatics CNN FDA BBB RNA MACCS GNN FNN ECFP DL t-SNE CNS FP Molecular Descriptors CDK SVM Machine Learning FS ADMET ADR AUC MD KEGG ML WHO OOB APFP AI GO SMILES MCC Drug Discovery Deep Learning TCGA PCA MKL GEO CV GCN NB RF QSAR DNA CPI
ISSN:	2001-0370, 2001-0370
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Popis
Shrnutí:	[Display omitted] •Machine Learning in drug discovery has greatly benefited the pharmaceutical industry.•Application of machine algorithms must entail a robust design in real clinical tasks.•Trending machine learning algorithms in drug design: NB, SVM, RF and ANN. Drug discovery aims at finding new compounds with specific chemical properties for the treatment of diseases. In the last years, the approach used in this search presents an important component in computer science with the skyrocketing of machine learning techniques due to its democratization. With the objectives set by the Precision Medicine initiative and the new challenges generated, it is necessary to establish robust, standard and reproducible computational methodologies to achieve the objectives set. Currently, predictive models based on Machine Learning have gained great importance in the step prior to preclinical studies. This stage manages to drastically reduce costs and research times in the discovery of new drugs. This review article focuses on how these new methodologies are being used in recent years of research. Analyzing the state of the art in this field will give us an idea of where cheminformatics will be developed in the short term, the limitations it presents and the positive results it has achieved. This review will focus mainly on the methods used to model the molecular data, as well as the biological problems addressed and the Machine Learning algorithms used for drug discovery in recent years.
Bibliografie:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23
ISSN:	2001-0370 2001-0370
DOI:	10.1016/j.csbj.2021.08.011